|
RWE: use of target trial emulation framework: why aiming to emulate RCT?
|
|
4
|
1070
|
December 3, 2024
|
|
Analyzing compositional outcome data
|
|
6
|
3999
|
November 22, 2024
|
|
Presenting data for extremely small n size clinical trials
|
|
2
|
796
|
October 27, 2024
|
|
Prior design in a bayesian re-analysis of an RCT
|
|
4
|
1133
|
October 20, 2024
|
|
Use of percentage change in clinical trials
|
|
17
|
9375
|
July 22, 2024
|
|
ITT analysis under equally high non-adherence in both arms in RCT
|
|
4
|
1048
|
June 9, 2024
|
|
Run-in phase in RCTs
|
|
14
|
10454
|
April 1, 2024
|
|
Communicating statistical concerns to the FDA
|
|
3
|
1344
|
March 11, 2024
|
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
1122
|
February 23, 2024
|
|
Assessing correlation/surrogacy between 2 estimated treatment effects
|
|
9
|
1940
|
February 17, 2024
|
|
Review of Trial at the Center of the Firestorm Over Early Connection of Patients to Ventilators during the Pandemic
|
|
34
|
5643
|
February 16, 2024
|
|
RCT: protocol deviation and implications for analysis
|
|
6
|
1311
|
February 16, 2024
|
|
Time to pre-randomization monthly seizure count
|
|
1
|
1161
|
February 8, 2024
|
|
ITT analysis population - RCT
|
|
6
|
1764
|
February 3, 2024
|
|
Ranked analysis of ANCOVA
|
|
7
|
3199
|
January 21, 2024
|
|
Bayesian Dynamic Borrowing with Robust Mixture Priors: Fair or not?
|
|
7
|
2471
|
January 18, 2024
|
|
Language for communicating frequentist results about treatment effects
|
|
200
|
124589
|
January 9, 2024
|
|
Substituting treatment arm with drug exposure (continuous variable) in RCT
|
|
10
|
1582
|
January 8, 2024
|
|
Encryption of dataset in REDCap
|
|
3
|
1459
|
December 15, 2023
|
|
Mixed models modelling
|
|
14
|
3066
|
October 26, 2023
|
|
Summary Statistics vs Raw Data
|
|
9
|
11165
|
October 23, 2023
|
|
Comparing "all active dose" to placebo - do we treat "all active dose" as one group or separate groups?
|
|
2
|
1108
|
September 4, 2023
|
|
Guidance of analysis of longitudinal patient reported outcomes w.r.t Joint models
|
|
4
|
1722
|
August 29, 2023
|
|
Effect modification in series of n-of-1 trials (repeated crossover)
|
|
2
|
1090
|
August 25, 2023
|
|
Data collected outside of guidelines/window
|
|
10
|
3614
|
June 13, 2023
|
|
Different results in unconstrained partial proportional odds model
|
|
0
|
1311
|
May 22, 2023
|
|
Attrition Sensitive Randomisation
|
|
1
|
1443
|
April 25, 2023
|
|
Randomization in a diagnostic study - necessary?
|
|
3
|
1577
|
March 16, 2023
|
|
Appropriate model for combined data from two RCTs
|
|
10
|
1339
|
March 8, 2023
|
|
RCT with missing follow-up outcomes: ANCOVA + MI vs Mixed-Effects Modelling?
|
|
50
|
9647
|
March 7, 2023
|